Amid the myriad treatments available for addressing issues related to erectile dysfunction and female sexual dysfunction, it can be overwhelming to navigate the vast array of options. Here at our clinic, we are at the forefront of applying cutting-edge technology and scientific advancements to effectively treat these conditions.
One of the most recent breakthroughs in the realm of treatment involves the innovative use of a method known as peptide therapy, offering new hope for cases that have previously proven resistant to conventional treatments.
Why Peptides?
Peptides represent a distinctive class of pharmaceutical compounds characterized by their intermediate size, falling between small molecules and larger proteins. From a biochemical and therapeutic standpoint, peptides possess unique properties that have been harnessed in the field of medicine for decades.
Many peptides function as inherent signaling molecules for various essential physiological processes, closely resembling the natural pathways within our bodies. In fact, several peptide drugs serve as vital “replacement therapies” to compensate for deficiencies in specific medical conditions, such as insulin for individuals with diabetes.
Compared to conventional small-molecule drugs, peptides and proteins exhibit a high degree of selectivity due to their multiple points of interaction with the target. This heightened selectivity can often lead to reduced side effects and lower toxicity.
Peptides can be engineered to target a wide range of molecules, rendering them an incredibly versatile tool in various medical fields, including oncology, immunology, infectious diseases, and endocrinology.
Peptide therapy has recently made significant inroads into the realm of sexual health, contributing to the overall success rate of treatments for both erectile dysfunction and female sexual dysfunction.
A specific peptide with tailored applications for addressing these conditions is bremelanotide, classified as a melanocortin receptor agonist. While this class of peptides has been acknowledged for its potential to enhance sexual function for some time, recent advancements have fine-tuned their effectiveness, hastened their response times, and minimized undesirable side effects.
Erectile Dysfunction and Female Sexual Dysfunction
Erectile Dysfunction (ED) is a highly prevalent condition experienced primarily by men, with its occurrence escalating as individuals age. Up to 20% of men contend with moderately severe ED, a percentage that significantly rises among those aged 60 and older.
Various underlying medical conditions can either contribute to or trigger ED, including depression, diabetes, cardiovascular issues, and neurological disorders. Notably, bremelanotide has been investigated and proven to enhance erectile function, particularly among men with diabetes-induced ED.
Female Sexual Dysfunction (FSD) encompasses a wide spectrum of concerns, encompassing low desire, insufficient lubrication, absence of orgasm or satisfaction, and discomfort during sexual activity.
Due to its multifaceted nature, FSD is widespread and tends to become more prevalent with age, affecting an estimated 75% of women by the time they reach their forties. Research has demonstrated the efficacy of bremelanotide in premenopausal women, offering relief from FSD, regardless of its underlying causes.
What Does Peptide Therapy Entail?
At our clinic, peptide therapy is administered via subcutaneous injections, with results emerging in as little as a few hours. Men can anticipate improved erectile function, coupled with heightened libido.
For women, increased desire, enhanced lubrication, and greater satisfaction are common outcomes. The effects are sustained for up to three days, and injections can be administered up to twice a week. This innovative therapy offers new hope and effective solutions for individuals grappling with these intimate health concerns.